The treatment of asthma in children: Inhaled corticosteroids

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 5, 2007, Pages 473-482

  Ricciardolo, Fabio L M ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Asthmatic inflammation; Childhood asthma; Efficacy of inhaled corticosteroids; Inhaled corticosteroids; Safety of inhaled corticosteroids

Indexed keywords

ADENOSINE PHOSPHATE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; GAMMA INTERFERON; GLUCOCORTICOID; MOMETASONE FUROATE; NEDOCROMIL SODIUM; PREDNISONE; SALMETEROL; STEROID; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BONE METABOLISM; CHILDHOOD; CLINICAL TRIAL; DRUG ABSORPTION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GROWTH RETARDATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LOW DRUG DOSE; MAINTENANCE THERAPY; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RIB FRACTURE; VERTEBRA FRACTURE;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHILD; CONTROLLED CLINICAL TRIALS AS TOPIC; GLUCOCORTICOIDS; HUMANS; PATIENT COMPLIANCE;

EID: 34447499845     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2005.11.007     Document Type: Article

References (110)

1. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report. 2002 NIH publication no. 02-3659.
2. Cockcroft D.W. Pharmacologic therapy for asthma: overview and historical perspective. J Clin Pharmacol 39 (1999) 216-222
3. Laitinen L.A., Laitinen A., and Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 147 (1993) 697-704
4. Todd G., Dunlop K., McNaboe J., Ryan M.F., Carson D., and Shields M.D. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone proprionate. Lancet 348 (1996) 27-29
5. Second Expert Panel on the Management of Asthma. Guidelines for the diagnosis and management of asthma: NIH publication no. 97-4051 (1997), National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, Md
6. Belvisi M.G., and Hele D.J. Soft steroids: a new approach to the treatment of inflammatory airways disease. Pulm Pharmacol Ther 16 (2003) 321-325
7. O'Connor B., Bonnaud G., Haahtela T., Luna J.M., Querfurt H., Wegener T., et al. Dose-ranging study of mometasone furoate dry power inhaler in the treatment of moderate persistent asthma using fluticasone proprionate as an active comparator. Ann Allergy Asthma Immunol 86 (2001) 397-404
8. Dent G. Ciclesonide (Byk Gulden). Curr Opin Invest Drugs 3 (2002) 78-83
9. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 90 (1992) 32-42
10. Djukanovic R., Wilson J.W., Britten Y.M., Wilson S.J., Walls A.F., Poche W.F., et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma. Am Rev Respir Dis 145 (1992) 674-699
11. Jeffery P.K., Godfrey R.W., Adelroth E., Nelson F., Rogers A., and Johansson S.A. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 145 (1992) 890-899
12. Duddridge M., Ward C., Hendrick D.J., and Walters E.H. Changes in bronchoalveolar lavage inflammatory cells in asthmatic patients treated with high dose inhaled beclomethasone dipropionate. Eur Respir J 6 (1993) 489-497
13. Wilson J.W., Djukanovic R., Howarth P.H., and Holgate S.T. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Respir Crit Care Med 149 (1994) 86-90
14. Lundgren R., Soderberg M., Horstedt P., and Stenling R. Morphological studies on bronchial mucosal biopsies from asthmatics before and after ten year treatment with inhaled steroids. Eur Respir J 1 (1988) 883-889
15. Keatings V.M., Jatakanon A., Worsdell Y.M., and Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 155 (1997) 542-548
16. Woolley K.L., Gibson P.G., Carty K., Wilson A.J., Twaddell S.H., and Woolley M.J. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 154 (1996) 237-243
17. Gibson P.G., Wong B.J., Hepperle M.J., Kline P.A., Girgis Gabbardo A., Guyatt G., et al. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin Exp Allergy 22 (1992) 525-532
18. Rytila P., Pelkonen A.S., Metso T., Nikander K., Haahtela T., and Turpeinen M. Induced sputum in children with newly diagnosed mild asthma: the effect of 6 months of treatment with budesonide or disodium cromoglycate. Allergy 59 (2004) 839-844
19. Ricciardolo F.L.M., Sterk P.J., Gaston B., and Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 84 (2004) 731-765
20. Kharitonov S.A., Yates D., Robbins R.A., Logan-Sinclair R., Shinebourne E., and Barnes P.J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343 (1994) 133-135
21. Kharitonov S.A., Yates D.H., and Barnes P.J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 153 (1996) 454-457
22. Kharitonov S.A., Yates D.H., Chung K.F., and Barnes P.J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 9 (1996) 196-201
23. Stoeck M., Riedel R., Hochhaus G., Hafner D., Masso J.M., Scmidt B., et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 309 (2004) 249-258
24. Kanniess F., Richter K., Bohme S., Jorres R.A., and Magnussen H. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma. Pulm Pharmacol Ther 14 (2001) 141-147
25. Ricciardolo F.L., Timmers M.C., Geppetti P., van Schadewijk A., Brahim J.J., Sont J.K., et al. Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J Allergy Clin Immunol 108 (2001) 198-204
26. Bel E.H., Timmers M.C., Zwinderman A.H., Dijkman J.H., and Sterk P.J. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis 143 (1991) 109-113
27. Taylor D.A., Jensen M.W., Kanabar V., Engelstatter R., Steinijans V.W., Barnes P.J., et al. A dose dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5-monophosphate in asthmatic patients. Am J Respir Crit Care Med 160 (1999) 237-243
28. 20 for adenosine in asthma patients. Pulm Pharmacol Ther 18 (2005) 328-336
29. Krouwels F.H., van der Heijden J.F., Lutter R., van Neerven R.J., Jansen H.M., and Out T.A. Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms. Am J Respir Cell Mol Biol 14 (1996) 388-397
30. Kita H., Abu-Ghazaleh R., Sanderson C.J., and Gleich G.J. Effect of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol 87 (1991) 70-77
31. Wallen N., Kita H., Weiller D., and Gleich G.J. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 147 (1991) 3490-3495
32. Baigelman W., Chodosh S., Pizzuto D., and Cupples L.A. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am J Med 75 (1983) 929-936
33. Wempe J.B., Tammeling E.P., Koeter G.H., Haransson L., Venge P., and Postma D.S. Blood eosinophil numbers and activity during 24 h: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol 90 (1992) 757-765
34. Cohan V.L., Undem B.J., Fox C.C., Adkinson N.F., Lichtenstein L.M., and Schleimer R.P. Dexamethasone does not inhibit the release of mediators from human lung mast cells residing in airway, intestine or skin. Am Rev Respir Dis 140 (1989) 951-954
35. Linden M., and Brattsand R. Efects of a corticosteroid, budesonide, on alveolar macrophages and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1β and IL-6. Pulm Pharmacol 7 (1994) 43-47
36. Martinet N., Vaillant P., Charles T., Lambert J., and Martinet Y. Dexamethasone modulation of tumour necrosis factor-α (cachectin) release by activated normal human alveolar macrophages. Eur Respir J 5 (1992) 67-72
37. John M., Lim S., Seybold J., Witt C., O'Connor B., Barnes P.J., et al. Inhaled corticosteroids increase IL-10 but reduce MIP-1α, GM-CSF and IFN-γ release from alveolar macrophages in asthma. Am J Respir Crit Care Med 155 (1997) A287 [abstract]
38. Borish L., Mascali J.J., Dishuck J., Bearn W.R., Martin R.J., and Rosenwasser L.J. Detection of alveolar macrophage-derived IL-1β in asthma: inhibition with corticosteroids. J Immunol 149 (1992) 3078-3082
39. Jilma B., Stohlawetz P., Pernerstorfer T., Eichler H.G., Mullner C., and Kapiotis S. Glucocorticoids dose-dependently increase plasma levels of granulocyte colony stimulating factor in man. J Clin Endocrinol Metab 83 (1998) 1037-1040
40. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. J Immunol 193 (1995) 4719-4725
41. Schleimer R.P. Effects of glucocorticoids on inflammatory cells relevant to their therapeutic application in asthma. Am Rev Respir Dis 141 (1990) S59-S69
42. Boschetto P., Rogers D.F., Fabbri L.M., and Barnes P.J. Corticosteroid inhibition of airway microvascular leakage. Am Rev Respir Dis 143 (1991) 605-609
43. Van de Graaf E.A., Out T.A., Loos C.M., and Jansen H.M. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Am Rev Respir Dis 143 (1991) 362-368
44. Schweibert L.M., Stellato C., and Schleimer R.P. The epithelium as a target for glucocorticoid action in the treatment of asthma. Am J Respir Crit Care Med 154 (1996) S16-S20
45. Kwon O.J., Au B.T., Collins P.D., Baraniuk J.M., Adcock I.M., Chung K.F., et al. Inhibition of interleukin-8 expression in human cultured airway epithelial cells. Immunology 81 (1994) 389-394
46. Kwon O.J., Jose P.J., Robbins R.A., Schall T.J., Willialms T.J., and Barnes P.J. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 12 (1995) 488-496
47. Gaddie J., Reid I.W., Skinner C., Petrie G.R., Sinclair D.J., and Palmer K.N. Aerosol beclomethasone diproprionate: a dose-response study in chronic bronchial asthma. Lancet 2 (1973) 280-281
48. Ellul-Micallef R., and Johansson S.A. Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide. Br J Clin Pharmacol 15 (1983) 419-422
49. Toogood J.H., Baskerville J.C., Jennings B., Lefcoe N.M., and Johansson S. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 70 (1982) 288-298
50. Shapiro G., Bronsky E.A., LaForce C.F., Mendelson L., Pearlman D., Schwartz R.H., et al. The dose-related efficacy of budesonide administered via dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatr 132 (1998) 976-982
51. Pedersen S., and Hansen O.R. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol 95 (1995) 29-33
52. Alving K., Lundberg J.O.N., and Nordvall S.L. Dose-dependent reduction of exhaled nitric oxide in asthmatic children by inhaled steroids. Am J Respir Crit Care Med 151 (1995) A129 [abstract]
53. Dahl R., Lundback B., Malo J.L., Mazza A., Nieminen M.M., Saarelainen P., et al. A dose-ranging study of fluticasone proprionate in adult patients with moderate asthma. Chest 104 (1993) 1352-1358
54. Katz Y., Lebas F.X., Medley H.V., and Robson R. Fluticasone propionate 50 micrograms BID versus 100 micrograms BID in the treatment of children with persistent asthma. Fluticasone Proprionate Study Group. Clin Ther 20 (1998) 424-437
55. NAEPP Workshop Report. Expert panel report 2. Guidelines for the diagnosis and management of asthma. Publication no. 97-4051 (1997), National Institutes of Health. National Heart, Lung, and Blood Institute, Bethesda, MD
56. Boulet L.P., Becker A., Berube D., Beveridge R., and Ernst P. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 161 (1999) S1-S61
57. Allen D.B. Safety of inhaled corticosteroids in children. Pediatr Pulmonol 33 (2002) 208-220
58. Tjwa M.K. Budesonide inhaled via turbuhaler: a more effective treatment for asthma than beclomethasone diproprionate via rotahaler. Ann Allergy Asthma Immunol 75 (1995) 107-111
59. Fabbri L., Burge P.S., Croonenborgh L., Warlies F., Weeke B., Ciaccia A., et al. Comparison of fluticasone proprionate with beclomethasone diproprionate in moderate to severe asthma treated for one year. International Study Group. Thorax 48 (1993) 817-823
60. Hoekx J.C., Hedlin G., Pedersen W., Sorva R., Hollingworth K., and Efthimiou J. Fluticasone proprionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 μg/day. Eur Respir J 9 (1996) 2263-2272
61. Barnes N., Hallett C., and Harris T.A. An overview of morning peak expiratory flow rate (PEFR) for clinical trials comparing fluticasone proprionate (FP) with budesonide (BUD). Eur Respir J 9 (1996) 52s-53s
62. Postma D.S., Sevette C., Martinat Y., Schlosser N., Aumann J., and Kafe H. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J 17 (2001) 1083-1088
63. Drollmann A., Langdon C., Engelstatter R., et al. Ciclesonide is effective in the treatment of bronchial asthma. Eur Respir J 18 (2001) P681 [abstract]
64. MacKenzie C.A., Weinberg E.G., Tabachnik E., Taylor M., Havnen J., and Crescenzi K. A placebo controlled trial of fluticasone proprionate in asthmatic children. Eur J Pediatr 152 (1993) 856-860
65. Boner A.L., Comis A., Schiassi M., Venge P., and Piacentini G.L. Bronchial reactivity in asthmatic children at high and low altitude: effect of budesonide. Am J Respir Crit Care Med 151 (1995) 1194-1200
66. Price J.F., and Weller P.H. Comparison of fluticasone proprionate and sodium cromoglycate for the treatment of childooh asthma (an open parallel group study). Respir Med 89 (1995) 363-368
67. Waalkens H.J., van Essen Zandvliet E.E., Gerritsen J., Duiverman E.J., Kerrebijn K.F., and Knol K. The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children. Dutch CNSLD Study Group. Eur Respir J 6 (1993) 652-656
68. Masoli M., Weatherall M., and Beasley R. Fluticasone given once versus twice a day: meta-analysis. Respirology 10 (2005) 183-188
69. Masoli M., Weatherall M., Holt S., and Beasley R. Budesonide once versus twice-daily administration: meta-analysis. Respirology 9 (2004) 528-534
70. Bisgaard H., Munck S.L., Nielsen J.P., Petersen W., and Ohlsson S.V. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 336 (1990) 649-651
71. Connett G.J., and Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child 68 (1993) 85-87
72. Maayan C., Itzhaki T., Bar Yishay E., Gross S., Tal A., and Godfrey S. The functional response of infants with persistent wheezing to nebulized beclomethasone diproprionate. Pediatr Pulmonol 2 (1996) 9-14
73. Carlsen K., Leegaard J., Larsen S., and Orstavik I. Nebulized beclomethasone diprorpionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child 63 (1988) 1428-1433
74. Price J.F., Russell G., Hindmarsh P.C., Weller P., Heaf D.P., and Williams J. Growth during one year of treatment with fluticasone proprionate or sodium cromoglycate in children with asthma. Pediatr Pulmonol 24 (1997) 178-186
75. Meltzer E.O., Orgel H.A., Ellis E.F., Eigen H.N., and Hernstreet M.P. Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. J Allergy Clin Immunol 90 (1992) 2-11
76. Verberne A.A., Frost C., Roorda R.J., van der Laag H., and Kerrebijn K.F. One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med 156 (1997) 688-695
77. Edmunds A.T., Goldberg R.S., Duper B., Devichand P., and Follows R.M. A comparison of budesonide 800 micrograms and 400 micrograms via Turbohaler with disodium cromoglycate via Spinhaler for asthma prophylaxis in children. Br J Clin Res 5 (1994) 11-23
78. Agertoft L., and Pedersen S. Effects of long term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88 (1994) 373-381
79. Pauwels R.A., Pedersen S., Busse W.W., Tan W.C., Chen Y.Z., Ohlsson S.V., et al. START Investigators Group. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361 (2003) 1071-1076
80. van Essen Zandvliet E.E., Hughes M.D., Waalkens H.J., Duiverman E.J., and Kerrenijn K.F. Remission of chilhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved?: Dutch CNSLD Study Group. Eur Respir J 7 (1994) 63-68
81. Boushey H.A., Sorkness C.A., King T.S., Sullivan S.D., Fahy J.V., Lazarus S.C., et al. National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 352 (2005) 1519-1528
82. Harding S.M. The human pharmacology of fluticasone proprionate. Respir Med 84 (1990) 25-29
83. Todd G.R., Acerini C.L., Buck J.J., Murphy N.P., Ross-Russell R., Warner J.T., et al. Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate. Eur Respir J 19 (2002) 1207-1209
84. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med 159 (1999) 941-955
85. Doull I.J., Donovan S.J., Wood P.J., and Holgate S.T. Blood-spot cortisol in mild asthma: the effect of inhaled corticosteroids. Arch Dis Child 72 (1995) 321-324
86. Volovitz B., Amir J., Malik H., Kauschansky A., and Varsano I. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N Engl J Med 329 (1993) 1703-1708
87. Barnes P.J., Pedersen S., and Busse W.W. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 157 (1998) S1-S53
88. Simons F.E. Benefits and risks of inhaled glucocorticoids in children with persistent asthma. J Allergy Clin Immunol 102 (1998) S77-S84
89. Nicolaizik W.H., Marchant J.L., Preece M.A., and Warner J.O. Endocrine and lung function in asthmatic children on inhaled corticosteroids. Am J Respir Crit Care Med 150 (1994) 624-628
90. Broide J., Soferman R., Kivity S., Golander A., Dickstein G., Spirer Z., et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 80 (1995) 1243-1246
91. Agertoft L., and Pedersen S. Short-term knemometry and urine cortisol excretion in children treated with fluticasone proprionate and budesonide: a dose response study. Eur Respir J 10 (1997) 1507-1512
92. Ninan T.K., Reid I.W., Carter P.E., Smail P.J., and Russell G. Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma. Thorax 48 (1993) 599-602
93. Hele D.J., and Belvisi M.G. Novel therapies for the treatment of inflammatory airway disease. Expert Opin Invest Drugs 12 (2003) 5-18
94. Adinoff A.D., and Hollister J.R. Steroid-induced fracture and bone loss in patients with asthma. N Engl J Med 309 (1983) 265-268
95. Boulet L.P., Giguere M.C., Milot J., and Brown J. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 94 (1994) 796-803
96. Agertoft L., and Pedersen S. Bone densitometry in children treated for 3-6 years with high dose inhaled budesonide. Eur Respir J 6 (1993) 261S
97. Konig P., Hillman L., Cervantes C., Levine C., Maloney C., Douglass B., et al. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr 122 (1993) 219-226
98. Hopp R.J., Degan J.A., Phelan J., Lappe J., and Gallagher G.C. Cross-sectional study of bone density in asthmatic children. Pediatr Pulmonol 20 (1995) 189-192
99. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343 (2000) 1054-1063
100. Allen H.D., Thong I.G., Clifton-Bligh P., Holmes S., Nery L., and Wilson K.B. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 29 (2000) 188-193
101. Crowley S., Trivedi P., Risteli L., Risteli J., Hindmarsh P.C., and Brook C.G. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr 132 (1998) 409-413
102. Allen D.B., Bielory L., Derendorf H., Dluhy R., Colice G.L., and Szefler S.J. Inhaled corticosteroids: past lessons and future issues. Allergy Clin Immunol 12 (2003) S1-S40
103. Ninan T.K., and Russell G. Asthma, inhaled corticosteroid treatment, and growth. Arch Dis Child 67 (1992) 703-705
104. Delacourt C., Chomienne F., de Blic J., Paupe J., and Scheinmann P. Preservation of growth velocity in asthmatic children treated with high doses of inhaled beclomethasone dipropionate (BDP). Eur Respir J 4 (1991) 593S
105. Varsano I., Volovitz B., Malik H., and Amir Y. Safety of 1 year of treatment with budesonide in young children with asthma. J Allergy Clin Immunol 85 (1990) 914-920
106. Konig P., Ford L., Galant S., Lawrence M., Lemanske R., Mendelson L., et al. A 1-year comparison of the effects of inhaled fluticasone propionate (FP) and placebo on growth in prepubescent children with asthma. Eur Respir J 9 (1996) 294S
107. Agertoft L., and Pedersen S. Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide. J Allergy Clin Immunol 115 (2005) 940-945
108. Allen D.B., Mullen M., and Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 93 (1994) 967-976
109. Busse W.W., Chervinsky P., Condemi J., Lumry W.R., Petty T.L., Rennard S., and Townley R.G. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 101 (1998) 457-463
110. Baran D. A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma. Br J Dis Chest 81 (1987) 170-175